Tiansheng Pharmaceutical Group Co., Ltd.
002872.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.9B
Close$
$0.08
98.6% downside
Current Fair Value
98.6% downsideOvervalued by 98.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.90 Billion |
|---|---|
| Enterprise Value | $1.95 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.17 |
| Beta | 0.32 |
| Outstanding Shares | 318,000,000 |
Return
| Return on Equity | -2.23% |
|---|---|
| Return on Assets | -1.67% |
| Return on Invested Capital | -2.35% |
Valuation & Multiples
| P/E Ratio | -44.26 |
|---|---|
| PEG | 108.52 |
| Price to Sales | 5.66 |
| Price to Book Ratio | 0.94 |
| Enterprise Value to Revenue | 3.79 |
| Enterprise Value to EBIT | -39.65 |
| Enterprise Value to Net Income | -46 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Tiansheng Pharmaceutical Group Co., Ltd.
1,273 employees
CEO: Shuang Liu Tiansheng Pharmaceutical Group Co., Ltd. is engaged in the manufacturing and distribution of pharmaceutical products. The company supplies a broad spectrum of medications that address various therapeutic areas, including respiratory, dig...